Stay updated on Nivolumab & Brentuximab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Brentuximab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Brentuximab in Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs. It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-25T17:20:38.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T22:16:52.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:12:42.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error instead of the usual content. The HTML indicates a minimal error page with a 403 message and basic header/footer elements.
    Difference
    19%
    Check dated 2026-09-20T22:24:18.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Adds a funding reference: 2015 ( U.S. NIH Grant/Contract ). Updates the page revision to v3.6.6, replacing the previous revision v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-30T06:23:26.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.6.5, replacing v3.6.4. This reflects a minor platform update and does not alter study details or page content.
    Difference
    0.0%
    Check dated 2026-08-08T23:00:23.000Z thumbnail image

Stay in the know with updates to Nivolumab & Brentuximab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Brentuximab in Lymphoma Clinical Trial page.